Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.31 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | BCL2 | P10415 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2789946 | 0.92 | PDK2 (0.40) | PDK2AKR1A1AKR1B1 | |
| SCHEMBL12992830 | 0.90 | — | — | |
| SCHEMBL2793639 | 0.89 | PDK2 (0.38) | PDK2ALK | |
| SCHEMBL4248046 | 0.85 | PDK2 (0.33) | PDK2ALKAKR1A1AKR1B1 | |
| SCHEMBL29458875 | 0.82 | PDK2 (0.42) | PDK2ALKAKR1A1AKR1B1BCL2 | |
| SCHEMBL29294792 | 0.82 | PDK2 (0.42) | PDK2ALKAKR1A1AKR1B1BCL2 | |
| SCHEMBL5013191 | 0.82 | PDK2 (0.42) | PDK2ALKAKR1A1AKR1B1BCL2 | |
| SCHEMBL5063493 | 0.82 | PDK2 (0.42) | PDK2ALKAKR1A1AKR1B1BCL2 | |
| SCHEMBL29403081 | 0.82 | PDK2 (0.44) | PDK2AKR1A1AKR1B1BCL2 | |
| SCHEMBL204806 | 0.82 | PDK2 (0.44) | PDK2AKR1A1AKR1B1BCL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9115112-B2 | Aminoanthracene derivative and an organic electroluminescent element employing the same | DOOSAN CORPORATION (KR) | 2015-08-25 | — | — | US | disclosed |
| US-9115112-B2 | Aminoanthracene derivative and an organic electroluminescent element employing the same | DOOSAN CORPORATION (KR) | 2015-08-25 | — | — | US | disclosed |
| US-9115112-B2 | Aminoanthracene derivative and an organic electroluminescent element employing the same | DOOSAN CORPORATION (KR) | 2015-08-25 | — | — | US | disclosed |
| US-20120161615-A1 | AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | DOOSAN CORPORATION (KR) | 2012-06-28 | — | — | US | disclosed |
| US-20120161615-A1 | AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | DOOSAN CORPORATION (KR) | 2012-06-28 | — | — | US | disclosed |
| US-20120161615-A1 | AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | DOOSAN CORPORATION (KR) | 2012-06-28 | — | — | US | disclosed |
| WO-2010147318-A2 | AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | 주식회사 두산 (KR) | 2010-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120161615-A1 | AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | AADAT, ALAD, AAAS | PDK2 1566/4885ALK 438/4885AKR1A1 2276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.